BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6239935)

  • 1. [A case of adrenocortical carcinoma with Cushing's syndrome presenting unusual urinary 17-ketosteroid fractionation].
    Watanobe H; Kannari K; Murabayashi S; Kimura K; Takebe K; Ojima M; Suzuki K
    Gan No Rinsho; 1984 Nov; 30(14):1827-34. PubMed ID: 6239935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenocortical carcinoma with Cushing's syndrome presenting unusual urinary 17-ketosteroid fractionation.
    Watanobe H; Kannari K; Kimura K; Takebe K
    J Endocrinol Invest; 1985 Jun; 8(3):249-52. PubMed ID: 3161933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excretion patterns of urinary 17-KS and 17-OHCS in patients with Cushing's syndrome.
    Mizutani S; Sonoda T; Seki T; Matsumoto K
    Urol Int; 1974; 29(5):341-50. PubMed ID: 4276760
    [No Abstract]   [Full Text] [Related]  

  • 4. Qualitative alterations in urinary 17-ketosteroid excretion during aminoglutethimide administration.
    Horký K; Küchel O; Gregorvá I; Stárka L
    J Clin Endocrinol Metab; 1969 Feb; 29(2):297-9. PubMed ID: 4236926
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunolocalization of dehydroepiandrosterone sulfotransferase in normal and pathologic human adrenal gland.
    Sasano H; Sato F; Shizawa S; Nagura H; Coughtrie MW
    Mod Pathol; 1995 Dec; 8(9):891-6. PubMed ID: 8751327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pattern of urinary neutral 17-ketosteroids on the basis of thin layer chromatography].
    Detter F; Kollmeier W; Klingmüller V
    Z Klin Chem Klin Biochem; 1967 Jul; 5(4):153-5. PubMed ID: 4236096
    [No Abstract]   [Full Text] [Related]  

  • 7. CUSHING'S SYNDROME WITH HYPOGLYCEMIA CAUSED BY ADRENOCORTICAL CARCINOMA.
    EYMONTT MJ; GWINUP G; KRUGER FA; MAYNARD DE; HAMWI GJ
    J Clin Endocrinol Metab; 1965 Jan; 25():46-52. PubMed ID: 14252287
    [No Abstract]   [Full Text] [Related]  

  • 8. Excretion of urinary 17-hydroxycorticosteroids and 11-deoxy-17-oxosteroids by women using steroidal contraceptives.
    Bulbrook RD; Hayward JL
    Lancet; 1969 Nov; 2(7629):1033-5. PubMed ID: 4187543
    [No Abstract]   [Full Text] [Related]  

  • 9. An unusual profile of endocrine study in a patient with pre-Cushing's syndrome.
    Kodama C; Nakada T; Sasagawa I; Ishigooka M; Yamaguchi T; Suzuki H
    Int Urol Nephrol; 1993; 25(6):517-24. PubMed ID: 8175270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dehydroepiandrosterone sulfate as an indicator of adrenal androgen function.
    Lobo RA; Paul WL; Goebelsmann U
    Obstet Gynecol; 1981 Jan; 57(1):69-73. PubMed ID: 6450345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Urinary steroid profile in Cushing syndrome and in tumors of the adrenal cortex].
    Homoki J; Holl R; Teller WM
    Klin Wochenschr; 1987 Aug; 65(15):719-26. PubMed ID: 3041100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal lactation with Cushing's syndrome--a case report.
    Mahesh VB; Pria SD; Greenblatt RB
    J Clin Endocrinol Metab; 1969 Jul; 29(7):978-81. PubMed ID: 4240061
    [No Abstract]   [Full Text] [Related]  

  • 13. Discriminant function based on steroid abnormalities in patients with lung cancer.
    Rao LG
    Lancet; 1970 Aug; 2(7670):441-5. PubMed ID: 4195119
    [No Abstract]   [Full Text] [Related]  

  • 14. The relationship of urinary androgen metabolites to breast diseases including carcinoma.
    Wetchler BB; McCarrick J; Allerhand J; Dreiling DA
    Mt Sinai J Med; 1974; 41(5):682-6. PubMed ID: 4278335
    [No Abstract]   [Full Text] [Related]  

  • 15. Investigation of urinary steroid profiles as a diagnostic method in Cushing's syndrome.
    Phillipou G
    Clin Endocrinol (Oxf); 1982 May; 16(5):433-9. PubMed ID: 7083597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Case of Cushing's syndrome with remarkable daily fluctuation of urinary 17-OHCS].
    Inagaki H; Nakashio K; Koizumi S; Kogure H
    Nihon Rinsho; 1967 Nov; 25(11):2617-20. PubMed ID: 5628393
    [No Abstract]   [Full Text] [Related]  

  • 17. Different Types of Urinary Steroid Profiling Obtained by High-Performance Liquid Chromatography and Gas Chromatography-Mass Spectrometry in Patients with Adrenocortical Carcinoma.
    Velikanova LI; Shafigullina ZR; Lisitsin AA; Vorokhobina NV; Grigoryan K; Kukhianidze EA; Strelnikova EG; Krivokhizhina NS; Krasnov LM; Fedorov EA; Sablin IV; Moskvin AL; Bessonova EA
    Horm Cancer; 2016 Dec; 7(5-6):327-335. PubMed ID: 27370636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of urinary 17-hydroxycorticosteroid and 11-deoxy-17-oxosteroid excretion in obesity, in thyroid dysfunction and in early breast cancer.
    Sneddon A; Steel JM; Strong JA
    J Endocrinol; 1969 Feb; 43(2):48-9. PubMed ID: 4237784
    [No Abstract]   [Full Text] [Related]  

  • 19. Urinary steroid profile in adrenocortical tumors.
    Kikuchi E; Yanaihara H; Nakashima J; Homma K; Ohigashi T; Asakura H; Tachibana M; Shibata H; Saruta T; Murai M
    Biomed Pharmacother; 2000 Jun; 54 Suppl 1():194s-197s. PubMed ID: 10915023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of concurrent bilateral adrenocortical adenoma causing Cushing's syndrome].
    Koga F; Sumi S; Umeda H; Maeda S; Honda M; Hosoya Y; Yano M; Konita A; Suzuki S; Yoshida K
    Hinyokika Kiyo; 1997 Apr; 43(4):275-8. PubMed ID: 9161855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.